Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001415889-25-011581·Jade Biosciences, Inc.
Schedule 13D ownership disclosure
Jade Biosciences Inc
Common Stock, $0.0001 par value per share · CUSIP: 008064206
Event date: 2025-04-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.Reported CIK 0001346824
Shares: 1,324,954.00 · Class: 4.1%
- Peter KolchinskyReported CIK 0001384859
Shares: 1,324,954.00 · Class: 4.1%
- Rajeev ShahReported CIK 0001619841
Shares: 1,324,954.00 · Class: 4.1%
- RA Capital Healthcare Fund, L.P.Reported CIK 0001315082
Shares: 1,287,858.00 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-011581
- Form type
- SCHEDULE 13D/A
- Filer
- Jade Biosciences, Inc.
- CIK
- CIK 1798749
- Filed
- Apr 30, 2025
- Reporting period
- Apr 28, 2025
- Description
- Schedule 13D beneficial ownership